Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc H Scheetz

Showing results (21-30 of 221) with videos related to

Pageof 23
Sort By:
The Annals of Pharmacotherapy|February 25, 2010
Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritisLeslie Ray, Kimberly Levasseur, David P Nicolau, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2014
Projections for antiinfective drug shortages and time to actual resolutionMilena M McLaughlin, Zachary Pentoney, Erik Skoglund, et al.
Infectious Diseases and Therapy|September 20, 2014
Developing a Method for Reporting Patient Harm Due to Antimicrobial ShortagesMilena M McLaughlin, Erik Skoglund, Zachary Pentoney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve MonitoringJack Chang, Jiajun Liu, Keith S Kaye, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 23, 2015
Development of a pharmacy student research program at a large academic medical centerMilena M McLaughlin, Erik Skoglund, Scott Bergman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2013
Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusionsElizabeth Leung, Natarajan Venkatesan, Stephen C Ly, et al.
Expert Review of Anti-Infective Therapy|October 25, 2023
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agentsJack Chang, Ardita Tasellari, Jamie L Wagner, et al.
The Journal of Antimicrobial Chemotherapy|August 26, 2010
Determination of antibiotic dosage adjustments in patients with renal impairment: elements for successNimish Patel, Marc H Scheetz, George L Drusano, et al.
Diagnostic Microbiology and Infectious Disease|April 28, 2009
Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosaMarc H Scheetz, John S Esterly, Michael Malczynski, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 1, 2006
Applying antimicrobial pharmacodynamics to resistant gram-negative pathogensMarc H Scheetz, Kristin M Hurt, Gary A Noskin, et al.
Pageof 23

Showing results (21-30 of 221) with videos related to

Sort By:
Pageof 23
The Annals of Pharmacotherapy|February 25, 2010
Cerebral spinal fluid penetration of tigecycline in a patient with Acinetobacter baumannii cerebritisLeslie Ray, Kimberly Levasseur, David P Nicolau, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 19, 2014
Projections for antiinfective drug shortages and time to actual resolutionMilena M McLaughlin, Zachary Pentoney, Erik Skoglund, et al.
Infectious Diseases and Therapy|September 20, 2014
Developing a Method for Reporting Patient Harm Due to Antimicrobial ShortagesMilena M McLaughlin, Erik Skoglund, Zachary Pentoney, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2021
Vancomycin Duration of Therapy Can Inform the Need for Area Under the Curve MonitoringJack Chang, Jiajun Liu, Keith S Kaye, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 23, 2015
Development of a pharmacy student research program at a large academic medical centerMilena M McLaughlin, Erik Skoglund, Scott Bergman, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 21, 2013
Physical compatibility of vancomycin and piperacillin sodium-tazobactam at concentrations typically used during prolonged infusionsElizabeth Leung, Natarajan Venkatesan, Stephen C Ly, et al.
Expert Review of Anti-Infective Therapy|October 25, 2023
Contemporary pharmacologic treatments of MRSA for hospitalized adults: rationale for vancomycin versus non-vancomycin therapies as first line agentsJack Chang, Ardita Tasellari, Jamie L Wagner, et al.
The Journal of Antimicrobial Chemotherapy|August 26, 2010
Determination of antibiotic dosage adjustments in patients with renal impairment: elements for successNimish Patel, Marc H Scheetz, George L Drusano, et al.
Diagnostic Microbiology and Infectious Disease|April 28, 2009
Impact of dissimilar susceptibility breakpoints for doripenem on susceptibility and carbapenem discordance for Pseudomonas aeruginosaMarc H Scheetz, John S Esterly, Michael Malczynski, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 1, 2006
Applying antimicrobial pharmacodynamics to resistant gram-negative pathogensMarc H Scheetz, Kristin M Hurt, Gary A Noskin, et al.
Pageof 23